Martha Nason

Design and Analysis of Crossover Trials for Absorbing Binary Endpoints

Martha Nason, Dean Follmann, D. Follmann, 2010, Biometrics.

Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables

Richard T. Wyatt, Bette T. Korber, John R. Mascola, 2009, Journal of Virology.

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

Mario Roederer, Tongqing Zhou, Gary J. Nabel, 2010, Science.

HIV-1 Neutralization Coverage Is Improved by Combining Monoclonal Antibodies That Target Independent Epitopes

Michael S. Seaman, John R. Mascola, Martha Nason, 2012, Journal of Virology.

Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization

Tongqing Zhou, Lynn Morris, Gwo-Yu Chuang, 2013, Science.

Statistics and logistics: Design of Ebola vaccine trials in West Africa

Martha Nason, M. Nason, 2016, Clinical trials.